Insider Transactions in Q1 2021 at Alexion Pharmaceuticals, Inc. (ALXN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Ludwig Hantson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,332
-0.66%
|
$359,128
$154.03 P/Share
|
|
Mar 01
2021
|
Tanisha Carino EVP & CCAO |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-2.12%
|
$109,022
$151.75 P/Share
|
|
Feb 28
2021
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
7,616
+16.52%
|
-
|
|
Feb 28
2021
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+21.7%
|
-
|
|
Feb 28
2021
|
Aradhana Sarin EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+27.68%
|
-
|
|
Feb 28
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,033
+21.88%
|
-
|
|
Feb 28
2021
|
Brian Goff EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+21.05%
|
-
|
|
Feb 28
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,321
+23.65%
|
-
|
|
Feb 28
2021
|
Tanisha Carino EVP & CCAO |
BUY
Grant, award, or other acquisition
|
Direct |
18,033
+34.57%
|
-
|
|
Feb 28
2021
|
Ludwig Hantson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,725
+19.24%
|
-
|